Who owns PHOENIX BIOTECH ACQUISITION CLASS A?
- Ticker: CERO
- CUSIP Number: 71902k105
Tip: Access positions for across all investors
Analyze quarterly positions in Phoenix Biotech Acquisition Class A with up to 7 years of data, all consolidated into one spreadsheet
Download as csv

Top investors of Phoenix Biotech Acquisition Class A stock
Who bought or sold PHOENIX BIOTECH ACQUISITION CLASS A this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Arch Venture Corp | 9.4M | $564k | 550% | Dec 2024 |
|
Honkamp Krueger Financial Services | 2.6M | $155k | 90% | Dec 2024 |
|
Cubist Systematic Strategies | 333k | $20k | 100% | Dec 2024 |
|
JustInvest | 235k | $14k | 100% | Dec 2024 |
|
Goldman Sachs Group | 163k | $9.7k | 100% | Dec 2024 |
|
Selkirk Management LLC_____ | 121k | $7.3k | 0% | Dec 2024 |
|
Tower Research Capital | 74k | $4.4k | 1384% | Dec 2024 |
|
Millennium Management | 63k | $3.8k | 100% | Dec 2024 |
|
Jane Street | 58k | $3.4k | 1% | Dec 2024 |
|
Revolve Wealth Partners | 33k | $2.0k | 100% | Dec 2024 |
|
FNY Investment Advisers | 26k | $157k | 0% | Dec 2024 |
|
HBK Sorce Advisory | 26k | $1.6k | 100% | Dec 2024 |
|
SG Americas Securities | 26k | $2.0k | 100% | Dec 2024 |
|
Guidance Point Advisors | 19k | $1.1k | 100% | Dec 2024 |
|
Birchview Capital | 13k | $778.320000 | 0% | Dec 2024 |
|
Bank of America Corporation | 685.00 | $41.031500 | 195% | Dec 2024 |
|
Advisor Group Holdings | 400.00 | $36.000000 | 0% | Dec 2024 |
|
Jpmorgan Chase & Co | 140.00 | $7.994000 | 6900% | Dec 2024 |
|
Who sold out of Phoenix Biotech Acquisition Class A?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Geode Capital Management | Sep 2024 | 157k | $15k |
Hrt Financial | Sep 2024 | 80k | $7.0k |
Fifth Lane Capital | Sep 2024 | 77k | $6.9k |
XTX Topco | Sep 2024 | 57k | $5.3k |
CI Private Wealth | Sep 2024 | 15k | $1.4k |
Jump Financial | Sep 2024 | 12k | $1.1k |
Pineridge Advisors | Sep 2024 | 300.00 | $27.990000 |